Association analysis of apolipoprotein E genotype and risk of depressive symptoms in Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 19, Issue 2-3, 2005, Pages 154-157

  Craig, David ^a   Hart, Dominic J ^a   McIlroy, Stephen P ^a   Passmore, A Peter ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Alzheimer disease; Apolipoprotein E depression

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

AGED; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DYSPHORIA; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHIATRY; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; SYMPTOM; GENE FREQUENCY; GENETICS; GENOTYPE; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; RISK; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COHORT STUDIES; DEPRESSION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NORTHERN IRELAND; RISK;

EID: 20644451636     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082887     Document Type: Article

References (23)

1. Mortimer JA, Ebbitt B, Jun SP, Finch MD: Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology 1992;42:1689-1696.
2. Magni E, Binetti G, Bianchetti A, Trabucchi M: Risk of mortality and institutionalization in demented patients with delusions. J Geriatr Psychiatry Neurol 1996;9:123-126.
3. Finkel SI: Behavioural and psychological symptoms of dementia: A clinical and research update. Int Psychogeriatr 2000;12(suppl 1):9-12.
4. Olin JT, Katz IR, Meyers BS, Schneider LS, Lebowitz BD: Provisional diagnostic criteria for depression of Alzheimer disease: Rationale and background. Am J Geriatr Psychiatry 2002;10:129-141.
5. Zubenko GS: Neurobiology of major depression in Alzheimer's disease. Int Psychogeriatr 2000;12(suppl 1):217-230.
6. Pearlson GD, Ross CA, Lohr WD, Rovner BW, Chase GA, Folstein MF: Association between family history of affective disorder and the depressive syndrome of Alzheimer's disease. Am J Psychiatry 1990;147:452-456.
7. Strauss ME, Ogrocki PK: Confirmation of an association between family history of affective disorder and the depressive syndrome in Alzheimer's disease. Am J Psychiatry 1996;153: 1340-1342.
8. Levy ML, Cummings JL, Fairbanks LA, Sultzer DL, Small GW: Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's disease. Biol Psychiatry 1999;45:422-425.
9. Harwood DG, Barker WW, Ownby RL, St George-Hyslop P, Duara R: Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease. Am J Geriatr Psychiatry 7:119-123.
10. Muller-Thomsen T, Arlt S, Ganzer S, Mann U, Mass R, Naber D, Beisiegel U: Depression in Alzheimer's disease might be associated with apolipoprotein E epsilon 4 allele frequency in women but not in men. Dement Geriatr Cogn Disord 2002;14:59-63.
11. Holmes C, Russ C, Kirov G, Aitchison KJ, Powell JF, Collier DA, Lovestone S: Apolipoprotein E: Depressive illness, depressive symptoms, and Alzheimer's disease. Biol Psychiatry 1998;43:159-164.
12. Ballard C, Massey H, Lamb H, Morris C: Apolipoprotein E: Non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1997;63: 273-274.
13. Ramachandran G, Marder K, Tang M, Schofield PW, Chun MR, Devanand DP, et al: A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology 1996;47:256-259.
14. Lyketsos CG, Baker L, Warren A, Steele C, Brandt J, Steinberg M, et al: Depression, delusions, and hallucinations in Alzheimer's disease: No relationship to apolipoprotein E genotype. J Neuropsychiatry Clin Neurosci 1997;9: 64-67.
15. Bodmer JG, Kennedy LJ, Lindsay J, Wasik AM: Applications of serology and the ethnic distribution of three locus HLA haplotypes. Br Med Bull 1987;43:94-121.
16. Liede A, Cohen BB, Black DM, Davidson RH, Renwick A, Hoodfar E, et al: Evidence of a founder BRCA1 mutation in Scotland. Br J Cancer 2000;82:705-711.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
18. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
19. Kaufer DI, Cummings JL, Christine D, Bray T, Castellon S, Masterman D, et al: Assessing the impact of neuropsychiatrie symptoms in Alzheimer's disease: The Neuropsychiatrie Inventory Caregiver Distress Scale. J Am Geriatr Soc 1988;46:210-215.
20. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
21. Crook R, Hardy J, Duff K: Single-day apolipoprotein E genotyping. J Neurosci Methods 1994;53:125-127.
22. Eustace A, Coen R, Walsh C, Cunningham CJ, Walsh JB, Coakley D, Lawlor BA: A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease. Int J Geriatr Psychiatry 2002;17:968-973.
23. Hope T, Keene J, Fairbum CG, Jacoby R, McShane R: Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study. Br J Psychiatry 1999;174:39-44.